Experience

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Finance of America Funding LLC of $350 million aggregate…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NovoCure Limited of $575 million aggregate principal amount of its 0.000%…

Davis Polk advised the underwriters in connection with a $500 million Regulation S only offering by China SCE Group Holdings Limited of its 7.000% senior notes due 2025. China SCE Group…

Davis Polk advised the underwriters in the initial public offering of JW (Cayman) Therapeutics Co. Ltd on the Hong Kong Stock Exchange and an international offering and listing in reliance…

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14,375,000 shares of common stock of Atea Pharmaceuticals, Inc.,…

Davis Polk advised Coloplast on its acquisition of Nine Continents Medical, an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. The…

We advised the initial purchasers on the high-yield notes offering

Davis Polk is advising Ocado Group plc on its acquisition of Haddington Dynamics, a robotics-arm designer and manufacturer. Subject to satisfaction of certain closing conditions, the…

Davis Polk is advising Ocado Group plc on its acquisition of Kindred Systems, an advanced piece-picking robotics company, for approximately $262 million in cash, subject to typical purchase…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the follow-on offering of 3,506,098 shares of common stock of Allakos Inc…